OncLive SOSS

Updates in the Treatment of B-cell Lymphoma: Focus on Mantle Cell Lymphoma, Follicular Lymphoma, and Marginal Zone Lymphoma - Episode 2

Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma

December 23, 2021

Bijal D. Shah, MD, Caron Jacobson, MD, Michael Wang, MD, Ian W. Flinn, MD, PhD, Brian T. Hill, MD, PhD

Shared insight on the optimal selection and use of frontline therapy for patients who present with mantle cell lymphoma.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: An Overview of Mantle Cell Lymphoma and Frontline Therapy

EP. 2: Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma

EP. 3: Second-Line Therapy for MCL: Differentiating Available BTK Inhibitors

EP. 4: CAR T-cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma

EP. 5: Optimizing MCL Management: Sequencing and Combination Strategies

EP. 6: Clinical Pearls in the Management of Mantle Cell Lymphoma

EP. 7: Pathophysiology of Follicular Lymphoma and Frontline Therapy

EP. 8: Novel Therapies and Treatment Selection in Patients With Relapsed/Refractory FL

EP. 9: PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma

EP. 10: Optimizing the Sequencing of Therapy in Follicular Lymphoma

EP. 11: Clinical Pearls in the Management of Follicular Lymphoma

EP. 12: Frontline Treatment Options for Marginal Zone Lymphoma

EP. 13: Novel Treatment Strategies for Relapsed/Refractory MZL

EP. 14: Clinical Pearls in the Management of Marginal Zone Lymphoma

x